Hypoxic tumor kinase signaling mediated by STAT5A in development of castration-resistant prostate cancer.
In this study, we hypothesized that androgen-deprivation therapy (ADT) in prostate cancer, although initially efficient, induces changes in the tumor kinome, which subsequently promote development of castration-resistant (CR) disease. Recognizing the correlation between tumor hypoxia and poor progno...
Guardado en:
Autores principales: | Kathrine Røe, Åse Bratland, Ljiljana Vlatkovic, Harald Bull Ragnum, Marie Grøn Saelen, Dag Rune Olsen, Laure Marignol, Anne Hansen Ree |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/17199364992041ea834ef7596d33118e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting Inflammatory Signaling in Prostate Cancer Castration Resistance
por: Shangwei Zhong, et al.
Publicado: (2021) -
Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer
por: Nikolai A. Ognerubov
Publicado: (2021) -
Castration-resistant prostate cancer: potential targets and therapies
por: Parray A, et al.
Publicado: (2012) -
Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer
por: Jingsong Zhang, et al.
Publicado: (2017) -
Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer
por: Akash K. Kaushik, et al.
Publicado: (2016)